10,11-dihydro-10,11-dihydroxy-5h-dibenzazepine-5-carboxamide has been researched along with Kidney Diseases in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aldigier, JC; Darragon, T; Godbillon, J; Hillion, D; Jungers, P; Kourilsky, O; Lecaillon, JB; Menard, F; Meyer, P; Rouan, MC | 1 |
1 other study(ies) available for 10,11-dihydro-10,11-dihydroxy-5h-dibenzazepine-5-carboxamide and Kidney Diseases
| Article | Year |
|---|---|
The effect of renal impairment on the pharmacokinetics of oxcarbazepine and its metabolites.
Topics: Adult; Aged; Anticonvulsants; Carbamazepine; Female; Humans; Kidney Diseases; Male; Middle Aged; Oxcarbazepine | 1994 |